| Schedule Of Revenue By Region And Customer Type And Commercial Revenue By Product |
Revenue by region for the three and six-months ended June 30, 2026 and 2025 were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three-Months Ended |
|
Six-Months Ended |
|
|
June 30, 2026 |
|
June 30, 2025 |
|
June 30, 2026 |
|
June 30, 2025 |
|
Revenue by region: |
|
|
|
|
|
|
|
|
United States |
$ |
20,846 |
|
$ |
17,896 |
|
$ |
39,416 |
|
$ |
35,652 |
|
Japan |
|
387 |
|
|
427 |
|
|
826 |
|
|
1,061 |
|
European Union |
|
182 |
|
|
- |
|
|
315 |
|
|
49 |
|
Australia |
|
194 |
|
|
40 |
|
|
234 |
|
|
80 |
|
United Kingdom |
|
93 |
|
|
55 |
|
|
162 |
|
|
90 |
|
Total |
$ |
21,702 |
|
$ |
18,418 |
|
$ |
40,953 |
|
$ |
36,932 |
|
Revenue by customer type for the three and six-months ended June 30, 2026 and 2025 were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three-Months Ended |
|
Six-Months Ended |
|
|
June 30, 2026 |
|
June 30, 2025 |
|
June 30, 2026 |
|
June 30, 2025 |
|
Revenue by customer type: |
|
|
|
|
|
|
|
|
Commercial sales |
$ |
21,613 |
|
$ |
18,354 |
|
$ |
40,856 |
|
$ |
36,804 |
|
Deferred commercial revenue recognized |
|
9 |
|
|
8 |
|
|
17 |
|
|
17 |
|
BARDA revenue for right of first access |
|
80 |
|
|
56 |
|
|
80 |
|
|
111 |
|
Total |
$ |
21,702 |
|
$ |
18,418 |
|
$ |
40,953 |
|
$ |
36,932 |
|
Commercial revenue by product for the three and six-months ended June 30, 2026 and 2025 were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three-Months Ended |
|
Six-Months Ended |
|
|
June 30, 2026 |
|
June 30, 2025 |
|
June 30, 2026 |
|
June 30, 2025 |
|
Commercial revenue by product: |
|
|
|
|
|
|
|
|
RECELL |
$ |
19,049 |
|
$ |
16,819 |
|
$ |
36,170 |
|
$ |
34,494 |
|
Cohealyx |
|
1,744 |
|
|
330 |
|
|
3,244 |
|
|
357 |
|
PermeaDerm |
|
607 |
|
|
1,013 |
|
|
1,042 |
|
|
1,572 |
|
Lease revenue |
|
213 |
|
|
192 |
|
|
400 |
|
|
381 |
|
Total commercial sales |
$ |
21,613 |
|
$ |
18,354 |
|
$ |
40,856 |
|
$ |
36,804 |
|
|
| Summary of Consolidated Net Loss by Segment |
Consolidated net loss by segment for the three and six-months ended June 30, 2026 and 2025 were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three-Months Ended |
|
|
Six-Months Ended |
|
|
|
June 30, 2026 |
|
June 30, 2025 |
|
|
June 30, 2026 |
|
June 30, 2025 |
|
Total revenues |
|
$ |
21,702 |
|
$ |
18,418 |
|
|
$ |
40,953 |
|
$ |
36,932 |
|
Purchases of inventory |
|
|
(3,483 |
) |
|
(3,277 |
) |
|
|
(6,261 |
) |
|
(5,775 |
) |
Other cost of sales |
|
|
(452 |
) |
|
(192 |
) |
|
|
(1,197 |
) |
|
(528 |
) |
Gross profit |
|
|
17,767 |
|
|
14,949 |
|
|
|
33,495 |
|
|
30,629 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
|
(13,573 |
) |
|
(14,314 |
) |
|
|
(26,414 |
) |
|
(29,147 |
) |
General and administrative |
|
|
(5,971 |
) |
|
(6,666 |
) |
|
|
(12,032 |
) |
|
(13,057 |
) |
Research and development |
|
|
(5,078 |
) |
|
(5,117 |
) |
|
|
(10,707 |
) |
|
(11,400 |
) |
Total operating expenses |
|
|
(24,622 |
) |
|
(26,097 |
) |
|
|
(49,153 |
) |
|
(53,604 |
) |
Operating loss |
|
|
(6,855 |
) |
|
(11,148 |
) |
|
|
(15,658 |
) |
|
(22,975 |
) |
Interest expense |
|
|
(1,463 |
) |
|
(1,252 |
) |
|
|
(2,887 |
) |
|
(2,485 |
) |
Other income, net |
|
|
688 |
|
|
2,484 |
|
|
|
293 |
|
|
1,693 |
|
Loss before income taxes |
|
|
(7,630 |
) |
|
(9,916 |
) |
|
|
(18,252 |
) |
|
(23,767 |
) |
Income tax expense |
|
|
(33 |
) |
|
(4 |
) |
|
|
(22 |
) |
|
(12 |
) |
Net loss |
|
$ |
(7,663 |
) |
$ |
(9,920 |
) |
|
$ |
(18,274 |
) |
$ |
(23,779 |
) |
Other cost of sales consists of shipping costs, manufacturing scrap and overhead variances, and depreciation.
|